Loss of either p16/CDKN2 or retinoblastoma is required for overcoming senescence in human prostate epithelial cells.

被引：0
|
作者：
Jarrard, DF
Yeager, TR
Nassif, N
Sandefur, CE
Reznikoff, CA
机构：
来源：
JOURNAL OF UROLOGY | 1998年 / 159卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
266
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [1] p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells
    Jarrard, DF
    Sarkar, S
    Shi, Y
    Yeager, TR
    Magrane, G
    Kinoshita, H
    Nassif, N
    Meisner, L
    Newton, MA
    Waldman, FM
    Reznikoff, CA
    [J]. CANCER RESEARCH, 1999, 59 (12) : 2957 - 2964
  • [2] Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas
    Tsuzuki, T
    Tsunoda, S
    Sakaki, T
    Konishi, N
    Hiasa, Y
    Nakamura, M
    [J]. CANCER, 1996, 78 (02) : 287 - 293
  • [3] Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas
    Cohen, JA
    Geradts, J
    [J]. HUMAN PATHOLOGY, 1997, 28 (08) : 893 - 898
  • [4] Adenoviral p16/CDKN2 gene transfer to malignant glioma: Role of p16 in growth, invasion, and senescence
    Kim, SK
    Wang, KC
    Cho, BK
    Lim, SY
    Kim, YY
    Oh, CW
    Chung, YN
    Kim, CY
    Lee, CT
    Kim, HJ
    [J]. ONCOLOGY REPORTS, 2003, 10 (05) : 1121 - 1126
  • [5] CDKN2/p16 inactivation and p16 immunohistochemistry in astrocytic gliomas
    Piva, R
    Cavalla, P
    Bortolotto, S
    Cordera, S
    Grosso, R
    Richiardi, P
    Dutto, A
    Schiffer, D
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (01) : 55 - 58
  • [6] Regulation of p16(CDKN2) expression and its implications for cell immortalization and senescence
    Hara, E
    Smith, R
    Parry, D
    Tahara, H
    Steven, S
    Peters, G
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (03) : 859 - 867
  • [7] CHROMOSOME 9P ALLELIC LOSS AND P16/CDKN2 IN BREAST-CANCER AND EVIDENCE OF P16 INACTIVATION IN IMMORTAL BREAST EPITHELIAL-CELLS
    BRENNER, AJ
    ALDAZ, CM
    [J]. CANCER RESEARCH, 1995, 55 (13) : 2892 - 2895
  • [8] FREQUENCY OF HOMOZYGOUS DELETION AT P16/CDKN2 IN PRIMARY HUMAN TUMORS
    CAIRNS, P
    POLASCIK, TJ
    EBY, Y
    TOKINO, K
    CALIFANO, J
    MERLO, A
    MAO, L
    HERATH, J
    JENKINS, R
    WESTRA, W
    RUTTER, JL
    BUCKLER, A
    GABRIELSON, E
    TOCKMAN, M
    CHO, KR
    HEDRICK, L
    BOVA, GS
    ISAACS, W
    KOCH, W
    SCHWAB, D
    SIDRANSKY, D
    [J]. NATURE GENETICS, 1995, 11 (02) : 210 - 212
  • [9] CDKN2(p16)基因研究进展
    何正文
    曹亚
    [J]. 癌症, 1998, (01) : 75 - 77
  • [10] Inactivation of the p16/CDKN2 gene in carcinomas of the hypopharynx
    Liengswangwong, U
    Konishi, N
    Hiasa, Y
    Naito, H
    Yane, K
    [J]. CANCER LETTERS, 1999, 143 : S33 - S33
12345